Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 07, 2020

SELL
$46.4 - $67.43 $918,720 - $1.34 Million
-19,800 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $359,233 - $468,587
7,300 Added 58.4%
19,800 $1.26 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $557,750 - $616,750
12,500 New
12,500 $567,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lingohr & Partner Asset Management Gmb H Portfolio

Follow Lingohr & Partner Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.